Loading company…
Topotarget A/S developed biopharmaceutical therapies focused primarily on cancer and related diseases.
Topotarget A/S was a Danish biopharmaceutical company founded in 2000 and headquartered in Copenhagen. It focused on developing cancer treatments. In June 2005, it raised DKK 225 million in an IPO. In April 2014, it agreed to merge with BioAlliance Pharma; the financial terms were undisclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in